drugset / Trial / NCT04588688

Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency

NCT04588688

Phase 2 Terminated 3 enrolled Tobias Else Corcept Therapeutics · collab
NaSingle-groupOpen-labelDiagnostic

Summary

The researchers propose the use of mifepristone as an alternative way to test for Central Adrenal Insufficiency (CAI). They want to assess the feasibility of recruitment and the efficacy of the purposed method.

Timeline

Start
2021-05-05
Primary completion
2021-08-01
Completion
2021-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 600 mg Oral